Areas of Interest – Global
Please select a disease area to review all detailed information.
Kidney Transplantation
- Programs that enhance healthcare providers’ understanding of transplant‑related disease states.
- Initiatives aimed at improving access to healthcare for kidney transplant patients in underserved communities.
- Activities which support the advancement of scientific research in transplant immunology.
- Current challenges and new opportunities in diagnosing and treating antibody‑mediated rejection and microvascular inflammation in kidney transplant recipients.
- Education on the use of novel biomarkers to improve monitoring, diagnosis, and evaluation of treatment response in antibody‑mediated rejection and microvascular inflammation.
Lupus – Cutaneous Lupus Erythematosus (CLE)
- Strengthen early recognition and monitoring of CLE through biomarker research, advanced imaging technologies, and AI-enabled disease activity tools.
- Promote evidence‑based CLE care by supporting effective, steroid‑sparing treatments that reduce disease complications and improve outcomes.
- Integrate patient‑centered care by incorporating patient‑reported outcomes, lifestyle considerations, shared decision‑making, and adherence support, while addressing disparities in access to high‑quality dermatologic and rheumatologic care.
- Improve understanding of CLE by advancing natural history research that clarifies the biological and clinical distinctions between cutaneous and systemic lupus.
Lupus – Systemic Lupus Erythematosus (SLE)
- Advance SLE care by improving disease understanding, earlier diagnosis, risk stratification, and timely targeted biologic use.
- Support patient‑centered SLE management by incorporating patient‑reported outcomes, treat‑to‑target approaches, and strategies that address symptoms and improve treatment adherence.
- Improve health equity and care coordination by addressing gaps in access to SLE care and strengthening clinician education for managing complex disease presentations.